Accrol Group Holdings PLC Appointment of Joint Broker (0581S)
07 March 2023 - 6:00PM
UK Regulatory
TIDMACRL
RNS Number : 0581S
Accrol Group Holdings PLC
07 March 2023
7 March 2023
Accrol Group Holdings plc
("Accrol", the "Group" or the "Company")
APPOINTMENT OF JOINT BROKER
Accrol Group, the UK's leading independent tissue converter, is
pleased to announce the appointment of Shore Capital Stockbrokers
as Joint Broker, to work alongside Zeus, the Company's Nominated
Adviser and Joint Broker, with immediate effect.
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Richard Newman, Chief Financial Officer
Zeus (Nominated Adviser & Joint Broker)
Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512
Dominic King Tel: +44 (0) 203 829 5000
Shore Capital Stockbrokers (Joint Tel: +44 (0) 20 7408 4090
Broker)
Malachy McEntyre / Mark Percy / James
Thomas
Belvedere Communications Limited
Cat Valentine Tel: +44 (0) 7715 769 078
Keeley Clarke Tel: +44 (0) 7967 816 525
accrolpr@belvederepr.com
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and
supplier of toilet tissues, kitchen rolls, facial tissues, and wet
wipes to many of the UK's leading discounters and grocery retailers
across the UK. The Group now operates from six manufacturing sites,
including four in Lancashire, which together supply c.21.5%
(volume) of the UK tissue market valued at cGBP2.5bn at retail
sales value.
For more information, please visit www.accrol.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
APPDQLFBXXLBBBX
(END) Dow Jones Newswires
March 07, 2023 02:00 ET (07:00 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024